82 related articles for article (PubMed ID: 6460412)
1. [Influence of mononuclear cells on granulocyte macrophage progenitor cells (CFU-C) from patients with acute leukemia in remission (author's transl)].
Iizuka Y; Ohshima T; Amaki I
Nihon Ketsueki Gakkai Zasshi; 1981 May; 44(3):609-17. PubMed ID: 6460412
[No Abstract] [Full Text] [Related]
2. In vitro hematopoiesis following induction chemotherapy for acute leukemia.
Beyer GS; Bruno E; Hoffman R
Cancer Res; 1985 Nov; 45(11 Pt 2):5921-5. PubMed ID: 4053063
[TBL] [Abstract][Full Text] [Related]
3. [A clinical evaluation of the assay for granulocyte-macrophage colony forming unit (CFU-C) in acute non-lymphocytic leukemia].
Dan K
Rinsho Ketsueki; 1984 Mar; 25(3):322-8. PubMed ID: 6471434
[No Abstract] [Full Text] [Related]
4. [Bone marrow stromal precursor cells (CFU phi) in acute leukemia].
Domracheva EV; Kolesnikova AI; Rogova EM; Khoptynskaia SK; Brilliant MD
Probl Gematol Pereliv Krovi; 1981 Jul; 26(7):35-8. PubMed ID: 7279895
[No Abstract] [Full Text] [Related]
5. Significance of marrow-blood barrier for CFU-GM in patients with acute nonlymphoid leukemia (AnLL).
Ghizzi A; Carlo Stella C; Pedrazzoli P; Bobbio Pallavicini E; Gorini M; Ascari E
Haematologica; 1985; 70(4):303-8. PubMed ID: 3935527
[No Abstract] [Full Text] [Related]
6. In vitro bone marrow culture for colony forming units (CFU-C) in leukaemias and lymphomas.
Kushwaha MR; Upadhyay GC; Bagchi M; Malik KA; Mehrotra RM
Indian J Cancer; 1981 Mar; 18(1):13-9. PubMed ID: 7262902
[No Abstract] [Full Text] [Related]
7. Persistence of inhibitory activity against normal bone-marrow cells during remission of acute leukemia.
Broxmeyer HE; Grossbard E; Jacobsen N; Moore MA
N Engl J Med; 1979 Aug; 301(7):346-51. PubMed ID: 313511
[TBL] [Abstract][Full Text] [Related]
8. Comparison between cultures of granulocytic progenitor cells from bone marrow and from peripheral blood in acute leukemias. Preliminary report.
Gorini M; Ghizzi A; Tacchini V
Haematologica; 1979 Oct; 64(5):570-9. PubMed ID: 116917
[No Abstract] [Full Text] [Related]
9. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
[TBL] [Abstract][Full Text] [Related]
10. CFU-gm colony formation of peripheral blood and bone marrow in adult acute leukemia at presentation, during remission, and at relapse.
Jehn U; Wachholz K
Int J Cell Cloning; 1985 Jul; 3(4):199-213. PubMed ID: 3860564
[TBL] [Abstract][Full Text] [Related]
11. Acute leukemia in adults: assessment of remission induction with combination chemotherapy by clinical and cell-culture criteria.
Curtis JE; Cowan DH; Bergsagel DE; Hasselback R; McCulloch EA
Can Med Assoc J; 1975 Aug; 113(4):289-94. PubMed ID: 1056807
[TBL] [Abstract][Full Text] [Related]
12. [A case of acute leukemia, associated with sideroblastic bone marrow and terminated in erythroleukemic picture (author's transl)].
Nakayama S; Imai Y
Rinsho Ketsueki; 1972 Feb; 13(1):50-7. PubMed ID: 4533029
[No Abstract] [Full Text] [Related]
13. Abnormal responses of myeloid progenitor cells to granulocyte-macrophage colony-stimulating factor in human cyclic neutropenia.
Wright DG; LaRussa VF; Salvado AJ; Knight RD
J Clin Invest; 1989 Apr; 83(4):1414-8. PubMed ID: 2649515
[TBL] [Abstract][Full Text] [Related]
14. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors.
Carlo-Stella C; Tabilio A; Regazzi E; Garau D; La Tagliata R; Trasarti S; Andrizzi C; Vignetti M; Meloni G
Bone Marrow Transplant; 1997 Sep; 20(6):465-71. PubMed ID: 9313879
[TBL] [Abstract][Full Text] [Related]
15. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
[TBL] [Abstract][Full Text] [Related]
16. [New developments in understanding the compensatory hematological reactions and their outcomes in local fractionated therapeutic gamma irradiation].
Danilova MA; Kolesnikova AI; Pavlov VV; Bogatyreva TI; Konopliannikov AG; Lepekhina LA; Kal'sina SSh; Deniskina EF
Ter Arkh; 1997; 69(7):42-6. PubMed ID: 9424757
[TBL] [Abstract][Full Text] [Related]
17. [In vitro colony formation by normal and acute leukemic bone marrow in children (author's transl)].
Nishihira H; Nakahata T; Akabane T
Rinsho Ketsueki; 1975 Jun; 16(6):581-8. PubMed ID: 1172054
[No Abstract] [Full Text] [Related]
18. [Quantitative observation of leukemic cells and normal hematopoetic cells in the bone marrow during the treatment of acute leukemia (author's transl)].
Oshima T
Nihon Ketsueki Gakkai Zasshi; 1974 Apr; 37(2):73-92. PubMed ID: 4471882
[No Abstract] [Full Text] [Related]
19. Impact of in vivo administration of interleukin 3 on proliferation, differentiation, and chemosensitivity of acute myeloid leukemia.
Gore SD; Weng LJ; Jones RJ; Cowan K; Zilcha M; Piantadosi S; Burke PJ
Clin Cancer Res; 1995 Mar; 1(3):295-303. PubMed ID: 9815985
[TBL] [Abstract][Full Text] [Related]
20. Comparison of in vivo and in vitro effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with acute myeloid leukemia.
Estrov Z; Estey EH; Andreeff M; Talpaz M; Kurzrock R; Reading CL; Deisseroth AB; Gutterman JU
Exp Hematol; 1992 Jun; 20(5):558-64. PubMed ID: 1587302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
